These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. [Inhibition of lymphocyte transformation in the diffusion-chamber ("in vivo") by L-asparaginase]. Pappas A; Hirschmann WD; Scheurlen PG; Esser W Med Welt; 1970 Jul; 28():1288-91. PubMed ID: 5508100 [No Abstract] [Full Text] [Related]
5. [Nutritional requirement of cancer cells: inhibition of the growth of cancer cells by L-asparaginase]. Honjo T; Hayaishi O Tanpakushitsu Kakusan Koso; 1970 Apr; 15(5):515-23. PubMed ID: 4913828 [No Abstract] [Full Text] [Related]
6. [Antineoplastic activity of L-asparaginase]. Grgić Z Lijec Vjesn; 1969 Jul; 91(7):783-6. PubMed ID: 4910066 [No Abstract] [Full Text] [Related]
7. Biochemical method of cancer control. L-asparaginase in cancer chemotherapy. A review. Jayaram HN; Sirsi M Indian J Cancer; 1970 Mar; 7(1):71-7. PubMed ID: 4992298 [No Abstract] [Full Text] [Related]
8. A review of the preclinical antitumor activity and toxicology of L-asparaginase derived from E. coli. Charles LM; Bono VH Cancer Treat Rep; 1981; 65 Suppl 4():39-46. PubMed ID: 7049380 [No Abstract] [Full Text] [Related]
9. L-Asparaginase: discovery and development as a tumor-inhibitory agent. Broome JD Cancer Treat Rep; 1981; 65 Suppl 4():111-4. PubMed ID: 7049374 [No Abstract] [Full Text] [Related]
10. [Clinical significance of L-asparaginase]. Benkö S Orv Hetil; 1969 Aug; 110(35):2019-23. PubMed ID: 4900161 [No Abstract] [Full Text] [Related]
12. Immunosuppressive action of L-asparaginase. Alexander P Proc R Soc Med; 1972 Mar; 65(3):265-6. PubMed ID: 5083314 [No Abstract] [Full Text] [Related]
13. [A new antineoplastic drug: the L-asparaginase. Future possibilities of antitumor enzymotherapy]. Nervi C; Casale C; Cortese M Policlinico Prat; 1969 Mar; 76(10):297-304. PubMed ID: 5252042 [No Abstract] [Full Text] [Related]
14. In vitro test for sensitivity of leukemic cells to L-asparaginase. Schrek R; Dolowy WC Cancer Res; 1971 May; 31(5):523-6. PubMed ID: 4932205 [No Abstract] [Full Text] [Related]
15. [Lymphocytes after cytostatic therapy with L-asparaginase. Transformation rate, mitotic index and chromosomes]. Vormittag W; Pietschmann H Wien Klin Wochenschr; 1972 Jan; 84(4):64-7. PubMed ID: 5012929 [No Abstract] [Full Text] [Related]
16. [L-asparaginase, a new drug of antileukemic action]. Hernádi F Orv Hetil; 1969 Jan; 110(4):187-9. PubMed ID: 5779083 [No Abstract] [Full Text] [Related]
17. [The use of asparaginase preparations for the treatment of tumors and leukemia (review of the literature)]. Nikolaev AIa Probl Gematol Pereliv Krovi; 1969 Jul; 14(7):51-60. PubMed ID: 4903458 [No Abstract] [Full Text] [Related]
18. Antitumor activity and other biologic properties of L-asparaginase (NSC-109229)-a review. Adamson RH; Fabro S Cancer Chemother Rep; 1968 Oct; 52(6):617-26. PubMed ID: 4895425 [No Abstract] [Full Text] [Related]
19. [Antineoplastic activity of various bacterial enzyme preparations]. Pszczólska G; Krzemiński Z Pol Tyg Lek; 1969 Oct; 24(43):1660-3. PubMed ID: 4901697 [No Abstract] [Full Text] [Related]
20. In-vitro cytotoxicity of L-asparaginase on rodent and human neoplastic cells. Schrek R; Dolowy WC Lancet; 1970 Oct; 2(7675):722. PubMed ID: 4195957 [No Abstract] [Full Text] [Related] [Next] [New Search]